218 related articles for article (PubMed ID: 35788062)
1. YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis.
Sánchez-Díez S; Munoz X; Ojanguren I; Romero-Mesones C; Espejo D; Villar A; Gómez-Olles S; Cruz MJ
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2414-2423. PubMed ID: 35788062
[TBL] [Abstract][Full Text] [Related]
2. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.
Long X; He X; Ohshimo S; Griese M; Sarria R; Guzman J; Costabel U; Bonella F
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 27836954
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
[TBL] [Abstract][Full Text] [Related]
4. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis.
Ejima M; Okamoto T; Suzuki T; Miyazaki Y
Respir Investig; 2022 May; 60(3):369-378. PubMed ID: 34998715
[TBL] [Abstract][Full Text] [Related]
5. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis.
He J; Zhang J; Ren X
Front Immunol; 2022; 13():1041098. PubMed ID: 36532009
[TBL] [Abstract][Full Text] [Related]
6. Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis.
Ohnishi H; Miyamoto S; Kawase S; Kubota T; Yokoyama A
BMC Pulm Med; 2014 Aug; 14():129. PubMed ID: 25098177
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 and Serum Krebs von den Lungen-6 as Potential Predictive Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Liang B; Zhang Y; Ke D; Yan R; Jiang MN; Li L; Zhang LX; Zhao XG; Yuan GP; Xu B; Liu XM
Immunol Invest; 2024 Jun; ():1-12. PubMed ID: 38900045
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens.
Hanzawa S; Tateishi T; Ishizuka M; Inoue Y; Honda T; Kawahara T; Tomita M; Miyazaki Y
Respir Investig; 2020 Nov; 58(6):457-464. PubMed ID: 32698996
[TBL] [Abstract][Full Text] [Related]
9. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
11. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
12. Serum heat shock protein 47 levels in patients with drug-induced lung disease.
Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Matsuoka Y; Kubota H; Mine M; Mukae H; Nagata K; Kohno S
Respir Res; 2013 Nov; 14(1):133. PubMed ID: 24256690
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
[No Abstract] [Full Text] [Related]
14. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
16. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.
Furuhashi K; Suda T; Nakamura Y; Inui N; Hashimoto D; Miwa S; Hayakawa H; Kusagaya H; Nakano Y; Nakamura H; Chida K
Respir Med; 2010 Aug; 104(8):1204-10. PubMed ID: 20347285
[TBL] [Abstract][Full Text] [Related]
17. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
[No Abstract] [Full Text] [Related]
18. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
19. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
[TBL] [Abstract][Full Text] [Related]
20. Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.
Jiang D; Xiao H; Dong R; Geng J; Xie B; Ren Y; Dai H
Clin Respir J; 2022 Mar; 16(3):234-243. PubMed ID: 35081277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
